Tabu announces Octavia Vodka deal
Online PR News – 13-February-2018 – Tabu Equity Investments Inc. (the “Company”) announces that it has signed a Letter of Intent with OCTAVIA VODKA LTD. allowing TABU to purchase 10% of OCTAVIA with shares issued by TABU, representing a $300,000 purchase price. The company expects to complete a share purchase agreement within 45 days. As part of the deal, OCTAVIA will licence the TABU brand for a special line of vodka, paying TABU an 8% royalty on sales.
Further, both companies have agreed to jointly develop an infused vodka product based on current and up and coming rules and regulations regarding infused drinks. Details of which will be announced over the year in time for new regulations regarding infused Cannabis beverages. Subsequent transactions may occur over a time span yet to be determined, but it is expected to be part of an overall definitive agreement. Both parties will also explore jointly, the possibility of new variations on infused beverages as they relate to Health Canada regulations.
Tabu Equity Investments Inc. invests in Canadian ACMPR applicants and licensed United States cannabis technology companies, as well as Canadian based support technologies for the cannabis industry. The company website can be found at: tabu.co
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Tabu’s periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should, aware" and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements including statements related to Tabu’s transactions and Business related to cannabis and future news releases. Although Tabu has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use Marijuana industry; and regulatory or political change.